BioSpace News Archive

Audentes Therapeutics, an Astellas Company, today announced that it is expanding its mission to develop potentially life-changing genetic medicines by becoming Astellas Gene Therapies.

Core One Labs Inc. WKN: A2P8K3), a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, is pleased to announce it has completed the acquisition of Ketamine Infusions Centers of Texas Inc., a U.S.-based health and wellness clinic that provides ketamine infusion therapy.

AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the fiscal year ended December 31, 2020 and provides a business update.

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it had closed its Series F Preferred Stock Financing on March 26, 2021

Based in Fort Worth, Texas, Sanara MedTech Inc. (NASDAQ:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter and full year ended December 31, 2020.

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Nacuity Pharmaceuticals, a Texas -based clinical stage pharmaceutical company, today announced that they have signed a Technology Proof of Concept (“PoC”) Agreement, with compensation on standard commercial terms.

Ipsen announced that the European Commission has approved Cabometyx® in combination with Bristol Myers Squibb’s Opdivo® for the first-line treatment of advanced renal cell carcinoma.

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 31 March 2021 consists of 454,509,503 ordinary shares of 1 pence each, none of which are held in treasury.

The global knee cartilage repair market was valued at approximately US$ 4.0 Bn in 2017.

Transparency Market Research has published a new report titled, “Physician Dispensed Cosmeceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.